A new study published online today in the journal Rheumatology demonstrates that there is a statistically significant increased risk of venous thromboembolism (VTE) – a condition which includes deep vein thrombosis and ...
Sep 24, 2014
0
0
Data from the BRIDGE clinical trial demonstrate that intravenous use of the drug cangrelor was effective at maintaining platelet inhibition in patients on thienopyridines who required bypass surgery. Trial results were presented ...
Nov 9, 2011
0
0
Interventional radiology treatments re-establish blood flow in people with chronic deep vein thrombosis (DVT), reducing disabling symptoms and improving the quality of life for those afflicted with post-thrombotic syndrome—an ...
Mar 26, 2012
0
0
(HealthDay)—The effect of psychological distress on clotting times and clotting factors varies in patients with venous thromboembolism (VTE) and depends on whether or not they are receiving oral anticoagulant (OAC) therapy, ...
Aug 26, 2012
0
0
Excess weight and body fat cause a range of heart and blood vessel diseases, according to the first study to investigate this using a method called Mendelian randomisation.
Jun 14, 2019
0
2
Percutaneous coronary intervention (PCI), also known as coronary angioplasty or angioplasty, is a procedure used to treat acute coronary syndromes. PCI involves opening a blocked blood vessel by threading and inflating a ...
Mar 24, 2012
0
0
(Medical Xpress) -- Patients who monitor their own treatment with warfarin or other blood-thinning drugs reduce their risk of developing blood clots by half, an Oxford University study has found.
Dec 1, 2011
0
0
Lowering phosphate intake in humans can reduce heart disease, according to research by experts at the University of Sheffield.
Jun 7, 2011
0
0
(HealthDay) -- After suffering a type of blood clot called a venous thromboembolism, patients usually take a blood-thinner such as warfarin (Coumadin). But aspirin may do just as well after a period of time, according to ...
May 23, 2012
2
0
(Medical Xpress)—For the first time, scientists at the UNC School of Medicine have shown that eliminating the enzyme factor XIII reduces the number of red blood cells trapped in a clot, resulting in a 50 percent reduction ...
Jul 3, 2014
0
0
